FACULTY
Seasonal and Pandemic Influenza: What Pharmacists Need to Know
The contents of this issue of University of Tennessee Advanced Studies in Pharmacy include proceedings from a consensus meeting conducted by the Johns Hopkins University School of Medicine on January 11, 2007
Activity Date: October 2007  — Activity Info: Volume 4, (12)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director reported the following:

PROGRAM DIRECTOR

Stephan L. Foster, PharmD, FAPhA
CAPT (Retired)
US Public Health Service
Associate Professor
Department of Clinical Pharmacy
University of Tennessee College of Pharmacy
Memphis, Tennessee
Dr Foster reports serving on the advisory board for Sanofi-Pasteur; and serving on the speakers’ bureau for Merck Vaccine.

Notice: In accordance with ACPE Criteria for Quality, the audience is advised that all faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

This University of Tennessee Advanced Studies in Pharmacy monograph is a part of the Influenza Educational Initiative (IEI). Please go to the IEI Web site for additional programs within this initiative, as well as program details and resources.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?